Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 14 15 16 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Noxxon Pharma N.V.. (9/29/17). "Press Release: Noxxon Supervisory Board Elects Experienced US & EU Biotech Veteran Don deBethizy Chairman". Berlin. 2017-09-29
Novartis AG. (9/28/17). "Press Release: Novartis and UC Berkeley Collaborate to Tackle »Undruggable« Disease Targets". Basel. 2017-09-28
Evotec AG. (9/28/17). "Press Release: Evotec Invests in Exscientia to Advance AI-driven Drug Discovery". Hamburg & Dundee. 2017-09-28
Immatics Biotechnologies GmbH. (9/28/17). "Press Release: Immatics Initiates the First Phase I Clinical Trial of its Unique ACTengine Approach in Patients with Advanced Solid Cancers". Houston, TX & Tübingen. 2017-09-28
Streck, Inc.. (9/28/17). "Press Release: Streck Signs Distribution Agreement with Orgentec SASU". La Vista, NE. 2017-09-28
Roche. (9/28/17). "Press Release: Roche’s Ocrevus (ocrelizumab) Approved in Switzerland for Primary Progressive and Relapsing Forms of Multiple Sclerosis". Basel. 2017-09-28
ThromboGenics N.V.. (9/28/17). "Press Release: ThromboGenics Successfully Introduces New »Already-Diluted« Formulation of Jetrea (ocriplasmin) in the US". Leuven. 2017-09-28
Basilea Pharmaceutica Ltd.. (9/28/17). "Press Release: Basilea Announces License Agreement for Antibiotic Zevtera (ceftobiprole) with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd.". Basel. 2017-09-28
Noxxon Pharma N.V.. (9/28/17). "Press Release: Noxxon Provides Update on Ongoing Phase 1/2 Clinical Trial with Lead Program NOX-A12". Berlin. 2017-09-28
Genedata AG. (9/27/17). "Press Release: Genedata Screener Strengthens Collaborative Research at Axxam". Basel. 2017-09-27
Endress+Hauser AG. (9/27/17). "Press Release: Endress+Hauser Inaugurates New Campus in Lyon". 2017-09-27
Oxford Immunotec Global plc. (9/27/17). "Press Release: Oxford Immunotec Announces Update in Patent Infringement Litigation". Oxford & Marlborough, MA. 2017-09-27
Bruker Corporation. (9/26/17). "Press Release: Bruker Announces Acquisition of Merlin to Add Selected Antibiotic Resistance and Susceptibility Testing to its MALDI Biotyper Microbial Identification Platform". Bremen. 2017-09-26
Juno Therapeutics, Inc.. (9/26/17). "Press Release: Juno Therapeutics Closes Follow-on Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares". Seattle, WA. 2017-09-26
Roivant Sciences GmbH. (9/26/17). "Press Release: Axovant Announces Negative Topline Results of Intepirdine Phase 3 MINDSET Trial in Alzheimer’s Disease". Basel. 2017-09-26
Novartis AG. (9/22/17). "Press Release: Novartis and The Max Foundation Transform Pioneering Cancer Access Program for People in Lower-income Countries". Basel. 2017-09-22
Juno Therapeutics, Inc.. (9/21/17). "Press Release: Juno Therapeutics Prices $250 Million Follow-on Offering". Seattle, WA. 2017-09-21
Juno Therapeutics, Inc.. (9/21/17). "Press Release: Juno Therapeutics Opens New Headquarters and Research Center". Seattle, WA. 2017-09-21
Humabs BioMed S.A.. (9/21/17). "Press Release: Data on Novel Bi-specific Antibody to Treat Zika Virus Infection Published in »Cell«". 2017-09-21
Abivax S.A.. (9/20/17). "Press Release: Abivax First-half 2017 Financial Results and Update". Paris. 2017-09-20
Roivant Sciences GmbH. (9/20/17). "Press Release: Roivant Sciences Launches Datavant to Improve Clinical Trials with Artificial Intelligence". San Francisco, CA & Basel. 2017-09-20
Novartis AG. (9/20/17). "Press Release: Novartis Drug Rydapt (midostaurin) Receives EU Approval for Newly Diagnosed FLT3-mutated Acute Myeloid Leukemia (AML) and Three Types of Advanced Systemic Mastocytosis (SM)". Basel. 2017-09-20
Nabriva Therapeutics plc. (9/19/17). "Press Release: Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $80 Million". Dublin & King of Prussia, PA. 2017-09-19
Transgene S.A.. (9/19/17). "Press Release: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers". Strasbourg. 2017-09-19
Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares". Dublin & King of Prussia, PA. 2017-09-18
Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Positive Topline Results from Global, Phase 3 Clinical Trial Evaluating IV and Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia". Dublin & King 2017-09-18
Roivant Sciences GmbH. (9/18/17). "Press Release: Urovant Sciences Appoints Keith A. Katkin as Chief Executive Officer". Basel. 2017-09-18
Bruker Corporation. (9/18/17). "Press Release: Bruker Launches the timsTOF Pro Mass Spectrometer to Enable the Revolutionary PASEF Method for Next-Generation Proteomics". Dublin. 2017-09-18
ThromboGenics N.V.. (9/18/17). "Press Release: ThromboGenics Regains Global Rights to Jetrea (ocriplasmin)". Leuven. 2017-09-18
High-Tech Gründerfonds Management GmbH. (9/18/17). "Press Release: Evonik Is Investing in Numaferm, a Specialist in the Biotechnological Production of Peptides". 2017-09-18
Ncardia. (9/18/17). "Press Release: Ncardia Established Following Pluriomics Axiogenesis Merger". Gosselies, Cologne, Leiden & Philadelphia, PA. 2017-09-18
Tolremo Therapeutics AG. (9/18/17). "Press Release: Tolremo Therapeutics AG – Preventing Drug Resistance in Cancer Therapy". Zürich. 2017-09-18
Bayer AG. (9/15/17). "Press Release: Bayer Receives Positive CHMP Opinion for Rivaroxaban 10 mg Once Daily for the Extended Prevention of Venous Thromboembolism [Not intended for U.S. and UK Media]". Berlin. 2017-09-15
Selexis S.A.. (9/15/17). "Press Release: Selvita Demonstrates Strong Revenue Growth in H1 2017". Kraków. 2017-09-15
Santhera Pharmaceuticals Holding AG. (9/15/17). "Press Release: Santhera Receives Negative Opinion from the CHMP for Its Marketing Authorization Application for Raxone in DMD and Intends to Appeal this Opinion". Liestal. 2017-09-15
Boehringer Ingelheim. (9/15/17). "Press Release: Boehringer Ingelheim Receives Positive CHMP Opinion for Adalimumab Biosimilar Cyltezo". Ingelheim. 2017-09-15
AB Sciex (d/b/a Sciex). (9/15/17). "Press Release: Sciex Announces the Appointment of Inese Lowenstein as President. Former President Jean-Paul Mangeolle to Retire". Framingham, MA. 2017-09-15
Adecco Group AG. (9/14/17). "Press Release: The Adecco Group Announces Acquisition of BioBridges". Zurich. 2017-09-14
Bayer AG. (9/14/17). "Press Release: Bayer and Ginkgo Bioworks Join Forces for Sustainable Agriculture, Forming New Company with USD 100 million Series A". Leverkusen & Boston, MA. 2017-09-14
Evotec AG. (9/14/17). "Press Release: Evotec and MaRS Innovation Establish Academic Bridge »LAB150« in Toronto". Hamburg. 2017-09-14
Leukocare AG. (9/14/17). "Press Release: Leukocare Continues to Expand and Invests in Research and Development". Munich. 2017-09-14
Lipotype GmbH. (9/13/17). "Press Release: Lipid Analysis for Early Stages of Drug Discovery – Customer Reference Flagship VentureLabs". 2017-09-13
Sophia Genetics S.A.. (9/13/17). "Press Release: Sophia Genetics Raises $30 Million in Series D Funding to Accelerate Its Mission of Democratizing Data-driven Medicine Worldwide". St. Sulpice. 2017-09-13
Genenta Science S.r.l.. (9/13/17). "Press Release: Genenta Raised Other $8,4 Million (€7 Million) in the Second Round of Financing - Total Raised in Two Rounds, $20,4 Million (€17 Million) -". Milano. 2017-09-13
Roivant Sciences GmbH. (9/13/17). "Press Release: Roivant Strengthens Executive Team with Key Hires and Promotions. Former GC of Pfizer Allen Waxman Joins Roivant". Basel. 2017-09-13
Affimed N.V.. (9/13/17). "Press Release: Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer". Heidelberg. 2017-09-13
BC Platforms. (9/13/17). "Press Release: BC Platforms Launches Unique Global Genomics and Clinical Data Analytics Resource". 2017-09-13
Transgene S.A.. (9/13/17). "Press Release: First Half-year 2017 in Line with Our Objectives – All Clinical Programs Progressing and New Collaboration Agreements Signed". Strasbourg. 2017-09-13
GreenLight Biosciences, Inc.. (9/13/17). "Press Release: GreenLight Biosciences Announces Series D Financing, Unveils RNA Strategy". Medford, MA. 2017-09-13
Bayer AG. (9/12/17). "Press Release: Wolfgang Nickl to Be New Chief Financial Officer at Bayer AG". Leverkusen. 2017-09-12
Berkeley Lights, Inc.. (9/12/17). "Press Release: Berkeley Lights Announces Strategic Project with Bayer Focused on Cell Line Development and Antibody Discovery". Emeryville, CA. 2017-09-12
DNA Script. (9/12/17). "Press Release: DNA Script Raises €11 Million ($13 Million) in Series A Financing Led by Illumina Ventures to Advance Development of Its DNA Synthesis Technology". Paris. 2017-09-12
Ayoxxa Biosystems GmbH. (9/11/17). "Press Release: Ayoxxa Introduces Lunaris, Its Advanced Fully Integrated Low-volume Beads-on-a-Chip Multiplex Protein Analysis System". Cologne. 2017-09-11
Bayer AG. (9/11/17). "Press Release: Bayer and Vanderbilt University Medical Center Collaborate to Develop Therapies against Kidney Diseases [Not intended for U.S. and UK Media]". Berlin. 2017-09-11
NMI TT Pharmaservices. (9/11/17). "Press Release: NMI TT Takes Over Global Zeptosens RPPA Chip Supply". Reutlingen & Berlin. 2017-09-11
Evotec AG. (9/8/17). "Press Release: European Investment Bank Supports Evotec’s Innovate Strategy with EUR 75 M Loan". Hamburg & Brussels. 2017-09-08
AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. 2017-09-08
Leap Therapeutics, Inc.. (9/8/17). "Press Release: Leap Therapeutics Announces Collaboration with EORTC to Evaluate DKN-01 in Combination with PD-L1 Cancer Immunotherapy and Chemotherapy In Esophagogastric and Biliary Tract Cancers". Cambridge, MA. 2017-09-08
Roche. (9/8/17). "Press Release: Roche Announces Progress in Biomarker Science in Cancer Immunotherapy at the European Society for Medical Oncology Congress". Basel. 2017-09-08
Epigenomics AG. (9/8/17). "Press Release: Epigenomics AG Issues Convertible Bonds". Berlin & Germantown, MD. 2017-09-08
Evotec AG. (9/7/17). "Press Release: Evotec and Abivax Enter into Strategic Collaboration to Develop Novel Antiviral Agents". Hamburg & Paris. 2017-09-07
BRAIN AG. (9/7/17). "Press Release: BRAIN AG Wins New Long-term Oriented Investor by Way of a Capital Increase. DAH Beteiligungs GmbH Is New, Long-term Oriented Investor of BRAIN AG Supporting Its Growth Strategy". Zwingenberg. 2017-09-07
BRAIN AG. (9/7/17). "Press Release: BRAIN AG Resolves Upon Capital Increase – New Long-term Investor Subscribes All New Shares [Ad-hoc News]". Zwingenberg. 2017-09-07
Bayer AG. (9/7/17). "Press Release: Bayer Submits Marketing Authorization Application for BAY94-9027 for the Treatment of Hemophilia A in the EU [Not intended for U.S. and UK Media]". Berlin. 2017-09-07
Boehringer Ingelheim. (9/7/17). "Press Release: Boehringer Ingelheim and Gubra Collaborate to Develop Next Generation Obesity Treatments". Ingelheim & Hørsholm. 2017-09-07
Markes International Ltd.. (9/7/17). "Press Release: Markes International Opens New Chinese Subsidiary in Shanghai". 2017-09-07
InflaRx GmbH. (9/7/17). "Press Release: InflaRx Reports Topline Phase IIa Clinical Results of IFX-1 for the Treatment of Hidradenitis Suppurativa". Jena. 2017-09-07
MorphoMed GmbH. (9/7/17). "Press Release: MorphoMed – New Start-up Focusing on Next-generation Tissue Engineering in Vienna". 2017-09-07
Merck & Co., Inc.. (9/6/17). "Press Release: Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology". Kenilworth, NJ & Munich. 2017-09-06
Bruker Corporation. (9/6/17). "Press Release: Bruker Announces the New D8 Discover Plus XRD System". Chiba. 2017-09-06
Metabolomic Discoveries GmbH. (9/5/17). "Press Release: Metabolon Acquires Metabolomic Discoveries GmbH". Research Triangle Park, NC. 2017-09-05
Immunic AG. (9/5/17). "Press Release: Immunic Therapeutics Adds New Investors and Completes Series A Financing Round of Total EUR 31.7 Million". Planegg-Martinsried. 2017-09-05
Merck KGaA. (9/5/17). "Press Release: Merck Prepares Strategic Options for the Consumer Health Business. Important Step in Executing Science and Technology Focused Strategy". Darmstadt. 2017-09-05
Amal Therapeutics S.A.. (9/5/17). "Press Release: Amal Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round". Geneva. 2017-09-05
Phenomenex, Inc.. (9/5/17). "Press Release: Phenomenex Announces Direct Sales and Support in Switzerland". Torrance, CA. 2017-09-05
Global Antibiotic Research and Development Partnership (GARDP). (9/4/17). "Press Release: More than EUR 56 Million Raised to Fund Initiative to Fight Antibiotic Resistance". Berlin. 2017-09-04
Allcyte GmbH. (9/4/17). "Press Release: Allcyte Collaborates with Boehringer Ingelheim to Advance Preclinical Oncology Drug Discovery by Using Novel Drug Response Profiling Technology". Vienna. 2017-09-04
Merck KGaA. (9/1/17). "Press Release: Successful Closing of Biosimilars Transaction". Darmstadt. 2017-09-01
Merck KGaA. (9/1/17). "Press Release: Heinrich Emanuel Merck Award for Analytical Science Goes to Professor Francesco Ricci". Darmstadt. 2017-09-01
Grünenthal GmbH. (9/1/17). "Press Release: Mark Fladrich Takes Office as the New CCO of the Grünenthal Group". Aachen. 2017-09-01
Amcure GmbH. (8/31/17). "Press Release: Amcure Receives Additional €1.75M BMBF Research Grant". Eggenstein-Leopoldshafen. 2017-08-31
Merck KGaA. (8/31/17). "Press Release: Driving Innovation in Cancer Care at ESMO 2017 with New Data in Hard-to-Treat Cancers [Not intended for U.K. or U.S. based media]". Darmstadt. 2017-08-31
Eurofins Scientific. (8/30/17). "Press Release: Eurofins Reports Solid H1 2017 Results with 15.6% Revenue Growth on the Back of an Organic growth of about 6% and over 35 Acquisitions". 2017-08-30
Evolva Holding S.A.. (8/30/17). "Press Release: Evolva Announces Major Restructuring for Next Phase of Its Development". 2017-08-30
Merck KGaA. (8/30/17). "Press Release: Merck Opens Its First Customer Food Safety Studio". Darmstadt. 2017-08-30
Medigene AG. (8/30/17). "Press Release: Medigene Presents Automated Platform for TCR Identification at CAR-TCR Summit". Planegg. 2017-08-30
Novartis AG. (8/30/17). "Press Release: Novartis Receives First Ever FDA Approval for a CAR-T Cell Therapy, Kymriah (CTL019), for Children and Young Adults with B-cell ALL that is Refractory or Has Relapsed at Least Twice". Basel. 2017-08-30
Epigenomics AG. (8/30/17). "Press Release: Epigenomics Commences Post Approval Study on Epi proColon". Berlin & Germantown, MD. 2017-08-30
Forge Therapeutics, Inc.. (8/29/17). "Press Release: Forge Therapeutics and Evotec to Present Preclinical Data on Novel Antibiotic Program at 2017 ASM/ESCMID Conference". San Diego, CA. 2017-08-29
Merck KGaA. (8/29/17). "Press Release: Merck Collaborates with Angiex to Speed Clinical Readiness of New Cancer Therapy". Darmstadt. 2017-08-29
Boehringer Ingelheim. (8/29/17). "Press Release: Boehringer Ingelheim Pharmaceuticals, Inc. Receives FDA Approval for Cyltezo (adalimumab-adbm), a Biosimilar to Humira, for the Treatment of Multiple Chronic Inflammatory diseases". Ingelheim & Ridgefield, 2017-08-29
DBV Technologies S.A.. (8/29/17). "Press Release: DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut". Montrouge. 2017-08-29
Thermo Fisher Scientific Inc.. (8/29/17). "Press Release: Thermo Fisher Scientific Completes Acquisition of Patheon". Waltham, MA. 2017-08-29
Kite Pharma, Inc.. (8/28/17). "Press Release: Gilead Sciences to Acquire Kite Pharma for $11.9 Billion. Immediately Positions Gilead as a Leader in Cell Therapy". Foster City, CA & Santa Monica, CA. 2017-08-28
European Invesmtent Bank (EIB). (8/28/17). "Press Release: Investment Plan for Europe – EIB Grants Financing to Apeiron". 2017-08-28
Merck KGaA. (8/28/17). "Press Release: Merck to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities". Darmstadt. 2017-08-28
Almirall S.A.. (8/28/17). "Press Release: Almirall Appoints Peter Guenter as New CEO". Barcelona. 2017-08-28
Mologen AG. (8/25/17). "Press Release: Mologen AG and Chinese iPharma Ltd. Signed Binding Term Sheet for a Collaboration Regarding the Development, Manufacture and Commercialization of Lefitolimod in China and a Potential Co-development". 2017-08-25
Kiadis Pharma N.V.. (8/25/17). "Press Release: Kiadis Pharma Announces Financial Results for the Six Months ended June 30, 2017". Amsterdam-Duivendrecht. 2017-08-25
Merck KGaA. (8/25/17). "Press Release: European Commission Grants Approval for Mavenclad (Cladribine Tablets)". Darmstadt. 2017-08-25
next pagenext page 1 2 3 ... 14 15 16 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top